Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Rapp

Showing results (141-150 of 214) with videos related to

Pageof 22
Sort By:
Scientific Reports|February 20, 2024
Retinal vessel caliber and cognitive performance: the multi-ethnic study of atherosclerosis (MESA)Nada El Husseini, Christopher L Schaich, Suzanne Craft, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 25, 2017
Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of AtherosclerosisTimothy M Hughes, Suzanne Craft, Laura D Baker, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 19, 2019
Corrigendum to: Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal WomenNicole M Armstrong, Mark A Espeland, Jiu-Chiuan Chen, et al.
JAMA Network Open|October 21, 2025
Preserved Cognitive Function After Statin Administration During Cancer Treatment With Doxorubicin: A Secondary Analysis of a Randomized Clinical TrialPamela J Grizzard, Nathaniel S O'Connell, Stephen R Rapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical TrialStephen R Rapp, L Doug Case, Ann Peiffer, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 22, 2019
Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal WomenNicole M Armstrong, Mark A Espeland, Jiu-Chiuan Chen, et al.
JAMA Internal Medicine|June 26, 2013
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 yearsMark A Espeland, Sally A Shumaker, Iris Leng, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 10, 2016
Predictors of Optimal Cognitive Aging in 80+ Women: The Women's Health Initiative Memory StudyJoseph S Goveas, Stephen R Rapp, Patricia E Hogan, et al.
Journal of Medicinal Chemistry|February 10, 2010
Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Pageof 22

Showing results (141-150 of 214) with videos related to

Sort By:
Pageof 22
Scientific Reports|February 20, 2024
Retinal vessel caliber and cognitive performance: the multi-ethnic study of atherosclerosis (MESA)Nada El Husseini, Christopher L Schaich, Suzanne Craft, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 25, 2017
Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of AtherosclerosisTimothy M Hughes, Suzanne Craft, Laura D Baker, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 19, 2019
Corrigendum to: Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal WomenNicole M Armstrong, Mark A Espeland, Jiu-Chiuan Chen, et al.
JAMA Network Open|October 21, 2025
Preserved Cognitive Function After Statin Administration During Cancer Treatment With Doxorubicin: A Secondary Analysis of a Randomized Clinical TrialPamela J Grizzard, Nathaniel S O'Connell, Stephen R Rapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical TrialStephen R Rapp, L Doug Case, Ann Peiffer, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 22, 2019
Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal WomenNicole M Armstrong, Mark A Espeland, Jiu-Chiuan Chen, et al.
JAMA Internal Medicine|June 26, 2013
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 yearsMark A Espeland, Sally A Shumaker, Iris Leng, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 10, 2016
Predictors of Optimal Cognitive Aging in 80+ Women: The Women's Health Initiative Memory StudyJoseph S Goveas, Stephen R Rapp, Patricia E Hogan, et al.
Journal of Medicinal Chemistry|February 10, 2010
Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Pageof 22